+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Biochips Market 2019-2027

  • ID: 4772784
  • Report
  • Region: Europe
  • 77 pages
  • Triton Market Research
1 of 4

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
Market Outlook

The biochips market in Europe is projected to develop at a CAGR of 18.91% during the forecasted years of 2019-2027. The growing application of biochips in the areas of biotechnology along with increased government funding in the development and promotion of biotechnology sector is fostering the growth of the biochips market in the European region.

The biochips market is segmented into three major divisions such as end-users, type, and substrate materials. Countries such as the United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe are studied in the Europe biochips market. The lack of awareness related to biochips, the unsettled regulatory guidelines and the availability of low-cost alternative technologies is majorly hindering the growth of the biochips market in the region. Nevertheless, factors such as growing innovation in the biochips market, evolving funds for R&D, and various initiatives adopted by the government to develop and promote biochips are the some of the reasons expected to propel the growth of the Europe biochips market in the coming years.

Competitive Outlook

The top players in the Europe biochips market are Perkinelmer Inc., Biomerieux Sa., Fluidigm Corporation, Merck Gmbh, Cepheid Inc., Illumina Inc., Gamida For Life Group., Origene Technologies Inc., Imgenex, Thermo Fisher Scientific Inc., Agilent Technology Inc., Biochain Institute Inc., Samsung Electronics Inc., Cybrdi Inc., and Bio-Rad Laboratories Inc.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
1. Biochips Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.3. Evolution & Transition of Biochips
2.4. Porter's Five Force Analysis
2.5. Market Attractiveness Matrix
2.6. Industry Components
2.7. Regulatory Framework
2.8. Vendor Scorecard
2.9. Key Impact Analysis
2.10. Market Opportunity Insights
2.11. Industry Player Positioning
2.12. Key Market Strategies
2.13. Market Drivers
2.13.1. Growth in Personalized Medicines
2.13.2. Rising Incidences & Treatment of Cancer
2.13.3. Constant Rise in Healthcare Spending Worldwide
2.13.4. Increasing Number of Investments in Biotechnology R&D
2.14. Market Restraints
2.14.1. Inequality in Healthcare Access
2.14.2. Inadequate Technical Awareness Related to Biochips
2.14.3. Complexity of Biological Systems
2.15. Market Opportunities
2.15.1. Developments in Biochips Technology
2.15.2. Widening Application Areas of Biochips
2.16. Market Challenges
2.16.1. Availability of Substitute Technologies
2.16.2. Unclear Regulatory Guidelines
2.16.3. Cost Constraints

3. Biochips Industry Outlook – By Type
3.1. Dna Chips
3.1.1. Agricultural Biotechnology
3.1.2. Cancer Diagnostics & Treatment
3.1.3. Drug Discovery
3.1.4. Gene Expression
3.1.5. Genomics
3.1.6. Single Nucleotide Polymorphism (Snp) Genotyping
3.1.7. Other Dna Chips
3.2. Lab On a Chip
3.2.1. Clinical Diagnostics
3.2.2. Drug Discovery
3.2.3. Genomics
3.2.4. Point of Care & in Vitro Diagnosis
3.2.5. Proteomics
3.2.6. Other Lab On a Chip
3.3. Protein Chips
3.3.1. Diagnostics
3.3.2. Drug Discovery
3.3.3. Expression Profiling
3.3.4. High Throughput Screening
3.3.5. Proteomics
3.3.6. Other Protein Chips
3.4. Other Chips
3.4.1. Cell Arrays
3.4.2. Tissue Arrays

4. Biochips Industry Outlook - By Substrate Material
4.1. Glass
4.2. Polymers
4.3. Silicon
4.4. Other Substrate Materials

5. Biochips Industry Outlook - By End User
5.1. Biotechnology and Pharmaceutical Companies
5.2. Hospitals and Diagnostics Centers
5.3. Academic and Research Institute

6. Biochips Industry - Europe
6.1. United Kingdom
6.2. Germany
6.3. France
6.4. Italy
6.5. Spain
6.6. Russia
6.7. Rest of Europe

7. Competitive Landscape
7.1. Agilent Technology Inc.
7.2. Biochain Institute Inc.
7.3. Biomerieux Sa
7.4. Bio-Rad Laboratories Inc.
7.5. Cepheid Inc.
7.6. Cybrdi Inc.
7.7. Fluidigm Corporation
7.8. Gamida For Life Group
7.9. Illumina Inc.
7.10. Imgenex
7.11. Merck Gmbh
7.12. Origene Technologies Inc.
7.13. Perkinelmer Inc.
7.14. Samsung Electronics Inc.
7.15. Thermo Fisher Scientific Inc.

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables
Table 1. Market Attractiveness Matrix For Biochips Market
Table 2. Vendor Scorecard of Biochips Market
Table 3. Regulatory Framework of Biochips Market
Table 4. Key Strategic Developments in Biochips Market
Table 5. Notable Investments Made in Biotechnology Industry in 2017
Table 6. Europe Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 7. Europe Biochips Market, By Type, 2019-2027 (In $ Million)
Table 8. Europe Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 9. Europe Biochips Market, By End User, 2019-2027 (In $ Million)

List of Figures
Figure 1. Europe Biochips Market, 2019-2027 (In $ Million)
Figure 2. Porter's Five Force Analysis of Biochips Market
Figure 3. Key Impact Analysis
Figure 4. Timeline of Biochips
Figure 5. Market Opportunity Insights, By Type, 2018
Figure 6. Market Opportunity Insights, By End User, 2018
Figure 7. Industry Components of Biochips Market
Figure 8. Key Player Positioning in 2018 (%)
Figure 9. Comparison of Healthcare Spending Per Capita and Out of the Pocket Health Expenditure
Figure 10. Europe Biochips Market, By Dna Chips, 2019-2027 (In $ Million)
Figure 11. Europe Dna Chips Market, By Agricultural Biotechnology, 2019-2027 (In $ Million)
Figure 12. Europe Dna Chips Market, By Cancer Diagnostics & Treatment, 2019-2027 (In $ Million)
Figure 13. Europe Dna Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 14. Europe Dna Chips Market, By Gene Expression, 2019-2027 (In $ Million)
Figure 15. Europe Dna Chips Market, By Genomics, 2019-2027 (In $ Million)
Figure 16. Europe Dna Chips Market, By Single Nucleotide Polymorphism (Snp) Genotyping, 2019-2027 (In $ Million)
Figure 17. Europe Dna Chips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 18. Europe Biochips Market, By Lab On a Chip, 2019-2027 (In $ Million)
Figure 19. Europe Lab On a Chip Market, By Clinical Diagnostics, 2019-2027 (In $ Million)
Figure 20. Europe Lab On a Chip Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 21. Europe Lab On a Chip Market, By Genomics, 2019-2027 (In $ Million)
Figure 22. Europe Lab On a Chip Market, By Point of Care & in Vitro Diagnosis, 2019-2027 (In $ Million)
Figure 23. Europe Lab On a Chip Market, By Proteomics, 2019-2027 (In $ Million)
Figure 24. Europe Lab On a Chip Market, By Other Lab On a Chip, 2019-2027 (In $ Million)
Figure 25. Europe Biochips Market, By Protein Chips, 2019-2027 (In $ Million)
Figure 26. Europe Protein Chips Market, By Diagnostics, 2019-2027 (In $ Million)
Figure 27. Europe Protein Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 28. Europe Protein Chips Market, By Expression Profiling, 2019-2027 (In $ Million)
Figure 29. Europe Protein Chips Market, By High Throughput Screening, 2019-2027 (In $ Million)
Figure 30. Europe Protein Chips Market, By Proteomics, 2019-2027 (In $ Million)
Figure 31. Europe Protein Chips Market, By Other Protein Chips, 2019-2027 (In $ Million)
Figure 32. Europe Biochips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 33. Europe Other Biochips Market, By Cell Arrays, 2019-2027 (In $ Million)
Figure 34. Europe Other Biochips Market, By Tissue Arrays, 2019-2027 (In $ Million)
Figure 35. Europe Biochips Market, By Glass, 2019-2027 (In $ Millions)
Figure 36. Europe Biochips Market, By Polymers, 2019-2027 (In $ Millions)
Figure 37. Europe Biochips Market, By Silicon, 2019-2027 (In $ Millions)
Figure 38. Europe Biochips Market, By Other Substrate Materials, 2019-2027 (In $ Millions)
Figure 39. Europe Biochips Market, By Biotechnology and Pharmaceutical Companies, 2019-2027 (In $ Millions)
Figure 40. Europe Biochips Market, By Hospitals and Diagnostics Centers, 2019-2027 (In $ Millions)
Figure 41. Europe Biochips Market, By Academic and Research Institute, 2019-2027 (In $ Millions)
Figure 42. Europe Biochips Market, Regional Outlook, 2018 & 2027 (In %)
Figure 43. United Kingdom Biochips Market, 2019-2027 (In $ Million)
Figure 44. Germany Biochips Market, 2019-2027 (In $ Million)
Figure 45. France Biochips Market, 2019-2027 (In $ Million)
Figure 46. Italy Biochips Market, 2019-2027 (In $ Million)
Figure 47. Spain Biochips Market, 2019-2027 (In $ Million)
Figure 48. Russia Biochips Market, 2019-2027 (In $ Million)
Figure 49. Rest of Europe Biochips Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AGilent Technology Inc.
  • Biochain Institute Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Cybrdi Inc.
  • Fluidigm Corporation
  • Gamida For Life Group
  • Illumina Inc.
  • Imgenex
  • Merck GmbH
  • Origene Technologies Inc.
  • Perkinelmer Inc.
  • Samsung Electronics Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4772784
Adroll
adroll